RBM3 and Parkinson disease: Moreover, after adding 1-methyl-4-phenylpyridinium (a dopaminergic neurotoxin) to the medium as PD in vitro model, RBM3 overexpression was able to diminish several apoptosis markers (Yang et al., 2018).